{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T23:45:56Z","timestamp":1788306356330,"version":"build-2803163510"},"reference-count":52,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T00:00:00Z","timestamp":1587513600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicines"],"abstract":"<jats:p>Background: Epstein\u2013Barr virus (EBV) infection is associated with significant morbidity and mortality in renal transplant (RT) recipients. The spectrum of illness ranges from infectious mononucleosis (IM) to post-transplant lymphoproliferative disorder (PTLD). In association with clinical signs and symptoms, virus-specific serology and heterophile antibody tests are widely used in confirming the diagnosis of IM in the general population. However, these tests may have a limited role in immunosuppressed RT recipients from seropositive donor, especially in children who were EBV-seronegative prior to the transplant. The aim of this study is to evaluate the utility of these tests in the early diagnosis of IM in this subset of patients. Methods: This is a case study with a review of literature. Results: Here, we present a 14-year-old male with hemophilia B who presented with fever, fatigue, sore throat, palatal petechial rash, exudative tonsillitis and cervical lymphadenopathy 3 months post-RT. He was EBV seronegative prior to RT and received a deceased donor kidney transplant from a seropositive donor. Induction was done with Thymoglobulin and maintenance immunosuppression consisted of tacrolimus and mycophenolate. Initial heterophile antibody test (monospot) was negative, but became positive at 5 months and remained positive at 9 months follow-up post-RT. EBV viral capsid antigens (VCA) IgM and IgG, early antigen (EA) and nuclear antigen (EBNA) were all negative at the time of presentation. VCA IgM and IgG both became positive at 5 months and peaked at 9 months follow-up, however the EA and EBNA remained negative. EBV viral load as measured by polymerase chain reaction (PCR) was negative for the first 3 months post-RT but became positive at presentation, peaked at 6 months and started declining thereafter. Peripheral blood smear examination showed no absolute and atypical lymphocytosis. Cytomegalovirus PCR in the blood and throat culture for streptococcus were negative. There was no splenomegaly. He was managed conservatively with intravenous fluids, bed rest, antipyretics and reduction of immunosuppression. Conclusions: EBV serological markers have a limited role in the early diagnosis of EBV-IM following RT in prior seronegative children. Initial heterophile antibody test may also be negative, and hence a repeat test may be necessary. Once becoming positive, the VCA IgM may remain persistently elevated for prolonged duration. In addition to the suppressed cellular immunity secondary to immunosuppression, humoral response to viral infections is also delayed in transplant recipients, especially in the early transplant period. Hence, routine monitoring with PCR is superior to serology in diagnosing IM early and monitoring the EBV infection post-RT for timely evaluation and management.<\/jats:p>","DOI":"10.3390\/medicines7040021","type":"journal-article","created":{"date-parts":[[2020,4,23]],"date-time":"2020-04-23T02:10:52Z","timestamp":1587607852000},"page":"21","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Limited Utility of Serology and Heterophile Test in the Early Diagnosis of Epstein\u2013Barr Virus Mononucleosis in a Child after Renal Transplantation"],"prefix":"10.3390","volume":"7","author":[{"given":"Alexandra","family":"Byrne","sequence":"first","affiliation":[{"name":"Department of Pediatrics, University of Florida, Gainesville, FL 32610, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Bush","sequence":"additional","affiliation":[{"name":"Division of Pediatric Nephrology, Department of Pediatrics, University of Florida, Gainesville, FL 32610, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felicia","family":"Johns","sequence":"additional","affiliation":[{"name":"Division of Pediatric Nephrology, Department of Pediatrics, University of Florida, Gainesville, FL 32610, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8441-0220","authenticated-orcid":false,"given":"Kiran","family":"Upadhyay","sequence":"additional","affiliation":[{"name":"Division of Pediatric Nephrology, Department of Pediatrics, University of Florida, Gainesville, FL 32610, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,4,22]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1093\/infdis\/139.5.553","article-title":"Primary infection with Epstein-Barr virus in infants in the United States","volume":"139","author":"Fleisher","year":"1979","journal-title":"J. Infect. Dis."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"3405","DOI":"10.1017\/S0950268817002515","article-title":"The role of the early social environment on epstein barr virus infection: A prospective observational design using the millennium cohort study","volume":"145","author":"Gares","year":"2017","journal-title":"Epidemiol. Infect."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1462399404008440","article-title":"Infectious mononucleosis and epstein-barr virus","volume":"6","author":"Vetsika","year":"2004","journal-title":"Expert Rev. Mol. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1128\/jvi.65.2.976-980.1991","article-title":"Epstein-Barr virus transmission via the donor organs in solid organ transplantation: Polymerase chain reaction and restriction fragment length polymorphism analysis of IR2, IR3, and IR4","volume":"65","author":"Cen","year":"1991","journal-title":"J. Virol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e416","DOI":"10.1097\/TXD.0000000000000852","article-title":"Infectious disease transmission in solid organ transplantation: Donor evaluation, recipient risk, and outcomes of transmission","volume":"5","author":"White","year":"2018","journal-title":"Transplant. Direct"},{"key":"ref_6","first-page":"62","article-title":"Pediatric renal transplantation","volume":"3","author":"Saeed","year":"2012","journal-title":"Int. J. Organ. Transplant. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1056\/NEJMra064928","article-title":"Infection in solid-organ transplant recipients","volume":"357","author":"Fishman","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"ref_8","first-page":"89","article-title":"Canadian PTLD Workshop Group\u20141999. Epstein-Barr virus infection in transplant recipients: Summary of a workshop on surveillance, prevention and treatment","volume":"13","author":"Allen","year":"2002","journal-title":"Can. J. Infect. Dis."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1097\/00007890-199911270-00015","article-title":"Epstein\u2013Barr virus-induced posttransplant lymphoproliferative disorders, ASTS\/ASTP EBV-PTLD Task Force and The Mayo Clinic Organized International Consensus Development Meeting","volume":"68","author":"Paya","year":"1999","journal-title":"Transplantation"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/nri1201","article-title":"B cells under influence: Transformation of B cells by epstein-barr virus","volume":"3","year":"2003","journal-title":"Nat. Rev. Immunol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1182\/blood.V83.9.2715.2715","article-title":"Direct correlation between the load of epstein-barr virus-infected lymphocytes in the peripheral blood of pediatric transplant patients and risk of lymphoproliferative disease","volume":"83","author":"Savoie","year":"1994","journal-title":"Blood"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1093\/infdis\/121.6.608","article-title":"Infectious-mononucleosis-like disease with negative heterophil agglutination test. Clinical features in relation to epstein-barr virus and cytomegalovirus antibodies","volume":"121","author":"Klemola","year":"1970","journal-title":"J. Infect. Dis."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1136\/bmj.297.6660.1363","article-title":"Clinical picture of primary HIV infection presenting as a glandular-fever-like illness","volume":"297","author":"Gaines","year":"1988","journal-title":"BMJ"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1093\/infdis\/166.5.986","article-title":"Quantitative oropharyngeal epstein-barr virus shedding in renal and cardiac transplant recipients: Relationship to immunosuppressive therapy, serologic responses, and the risk of posttransplant lymphoproliferative disorder","volume":"166","author":"Preiksaitis","year":"1992","journal-title":"J. Infect. Dis."},{"key":"ref_15","first-page":"1279","article-title":"Epstein-Barr virus infectious mononucleosis","volume":"70","author":"Ebell","year":"2004","journal-title":"Am. Fam. Physician"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1182\/blood.V57.5.933.933","article-title":"Clinical and laboratory evaluation of infants and children with epstein-barr virus-induced infectious mononucleosis: Report of 32 patients (aged 10\u201348 months)","volume":"57","author":"Horwitz","year":"1981","journal-title":"Blood"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1080\/10428190290016971","article-title":"Role of epstein-barr virus DNA load monitoring in prevention and early detection of post-transplant lymphoproliferative disease","volume":"43","author":"Stevens","year":"2002","journal-title":"Leuk. Lymphoma"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1093\/cid\/cis823","article-title":"Epidemiology and morbidity of epstein-barr virus infection in pediatric renal transplant recipients: A multicenter, prospective study","volume":"56","author":"Fickenscher","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/tid.12533","article-title":"Primary epsteinbBarr virus infection, seroconversion, and post-transplant lymphoproliferative disorder in seronegative renal allograft recipients: A prospective cohort study","volume":"18","author":"Alhomayeed","year":"2016","journal-title":"Transpl. Infect. Dis."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1182\/blood.V87.2.812.bloodjournal872812","article-title":"Epstein-Barr virus transmission from a blood donor to an organ transplant recipient with recovery of the same virus strain from the recipient\u2019s blood and oropharynx","volume":"87","author":"Alfieri","year":"1996","journal-title":"Blood"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1128\/JCM.39.4.1407-1415.2001","article-title":"Pediatric solid-organ transplant recipients carry chronic loads of epstein-barr virus exclusively in the immunoglobulin D-negative B-cell compartment","volume":"39","author":"Rose","year":"2001","journal-title":"J. Clin. Microbiol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1097\/00007890-198804000-00011","article-title":"The frequency of epstein-barr virus infection and associated lymphoproliferative syndrome after transplantation and its manifestations in children","volume":"45","author":"Ho","year":"1988","journal-title":"Transplantation"},{"key":"ref_23","first-page":"235","article-title":"Lymphoproliferative disorders in renal transplant recipients: Virologic aspects","volume":"6","author":"Preiksaitis","year":"1992","journal-title":"Clin. Transplant."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1093\/infdis\/152.5.876","article-title":"Epstein-Barr virus infections and DNA hybridization studies in posttransplantation lymphoma and lymphoproliferative lesions: The role of primary infection","volume":"152","author":"Ho","year":"1985","journal-title":"J. Infect. Dis."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1097\/TXD.0000000000000557","article-title":"Epstein-Barr Virus-positive posttransplant lymphoproliferative disease after solid organ transplantation: Pathogenesis, clinical manifestations, diagnosis, and management","volume":"2","author":"Nijland","year":"2015","journal-title":"Transplant. Direct"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1136\/jcp.21.5.631","article-title":"Horse agglutinins in infectious mononucleosis: III criterion for differential diagnosis","volume":"21","author":"Lee","year":"1968","journal-title":"J. Clin. Pathol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1056\/NEJM196601132740202","article-title":"Studies on the macroglobulins of human serum- polyclonal immunoglobulin class M (IgM) increase in infectious mononucleosis","volume":"274","author":"Wollheim","year":"1966","journal-title":"N. Engl. J. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1136\/archdischild-2016-311526","article-title":"How to use \u2026 the monospot and other heterophile antibody tests","volume":"102","author":"Heinz","year":"2017","journal-title":"Arch. Dis. Child. Educ. Pract. Ed."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1056\/NEJM200008173430707","article-title":"Epstein-Barr virus infection","volume":"343","author":"Cohen","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1056\/NEJM197911223012101","article-title":"Activation of suppressor T cells during epstein-barr-virus-induced infectious mononucleosis","volume":"301","author":"Tosato","year":"1979","journal-title":"N. Engl. J. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/0090-1229(84)90029-1","article-title":"Virologic, immunologic, and clinical observations on a patient during the incubation, acute, and convalescent phases of infectious mononucleosis","volume":"30","author":"Svedmyr","year":"1984","journal-title":"Clin. Immunol. Immunopathol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0928-0197(96)00245-0","article-title":"Evaluation of six commercially available kits using purified heterophile antigen for the rapid diagnosis of infectious mononucleosis compared with epstein-barr virus-specific serology","volume":"7","author":"Elgh","year":"1996","journal-title":"Clin. Diagn. Virol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1128\/jcm.25.12.2391-2394.1987","article-title":"Evaluation of latex-based heterophile antibody assay for diagnosis of acute infectious mononucleosis","volume":"25","author":"Cook","year":"1987","journal-title":"J. Clin. Microbiol."},{"key":"ref_34","unstructured":"Centre for Disease Control (2020, March 20). Epstein-Barr Virus and Infectious Mononucleosis: Laboratory Testing, Available online: http:\/\/www.cdc.gov\/epstein-barr\/laboratory-testing.html."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1038\/cti.2015.1","article-title":"Infectious mononucleosis","volume":"4","author":"Balfour","year":"2015","journal-title":"Clin. Transl. Immunol."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Van der Vries, E., Stittelaar, K.J., van Amerongen, G., Veldhuis Kroeze, E.J., de Waal, L., Fraaij, P.L., Meesters, R.J., Luider, T.M., van der Nagel, B., and Koch, B. (2013). Prolonged influenza virus shedding and emergence of antiviral resistance in immunocompromised patients and ferrets. PLoS Pathog., 9.","DOI":"10.1371\/journal.ppat.1003343"},{"key":"ref_37","first-page":"61","article-title":"Epstein-Barr virus, infectious mononucleosis, and posttransplant lymphoproliferative disorders","volume":"4","author":"Nalesnik","year":"1994","journal-title":"Transplant. Sci."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1128\/CDLI.7.3.451-456.2000","article-title":"Evaluation of 12 commercial tests for detection of epstein-barr virus-specific and heterophile antibodies","volume":"7","author":"Bruu","year":"2000","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1128\/CVI.00211-16","article-title":"Immunoglobulin M for Acute Infection: True or False?","volume":"23","author":"Landry","year":"2016","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Eckerle, I., Rosenberger, K.D., Zwahlen, M., and Junghanss, T. (2013). Serologic vaccination response after solid organ transplantation: A systematic review. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0056974"},{"key":"ref_41","first-page":"5","article-title":"Epstein-Barr virus-associated lymphoproliferative disorders","volume":"67","author":"Purtilo","year":"1992","journal-title":"Lab. Investig."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nri3803","article-title":"A brief history of T cell help to B cells","volume":"15","author":"Crotty","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.semcancer.2008.10.004","article-title":"Multiple roles of LMP1 in epstein-barr virus induced immune escape","volume":"18","author":"Middeldorp","year":"2008","journal-title":"Semin. Cancer Biol."},{"key":"ref_44","first-page":"83","article-title":"T lymphocyte anergy during acute infectious mononucleosis is restricted to the clonotypic receptor activation pathway","volume":"89","author":"Regueiro","year":"1992","journal-title":"Clin. Exp. Immunol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1182\/blood.V81.5.1393.1393","article-title":"Evidence for restricted epstein-barr virus latent gene expression and anti-EBNA antibody response in solid organ transplant recipients with post-transplant lymphoproliferative disorders","volume":"81","author":"Cen","year":"1993","journal-title":"Blood"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1128\/JCM.39.4.1211-1216.2001","article-title":"Toward standardization of epstein\u2013barr virus DNA load monitoring: Unfractionated whole blood as preferred clinical specimen","volume":"39","author":"Stevens","year":"2001","journal-title":"J. Clin. Microbiol."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) Transplant Work Group (2009). KDIGO clinical practice guideline for the care of kidney transplant recipients. Am. J. Transplant., 9, S1\u2013S155.","DOI":"10.1111\/j.1600-6143.2009.02834.x"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1093\/ndt\/gfr769","article-title":"Impact of epstein-barr virus donor and recipient serostatus on the incidence of post-transplant lymphoproliferative disorder in kidney transplant recipients","volume":"27","author":"Sampaio","year":"2012","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1128\/JCM.38.2.613-619.2000","article-title":"High levels of epstein-barr virus DNA in blood of solid-organ transplant recipients and their value in predicting posttransplant lymphoproliferative disorders","volume":"38","author":"Baldanti","year":"2000","journal-title":"J. Clin. Microbiol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1749-4486.2010.02187.x","article-title":"Challenging the use of the lymphocyte to white cell count ratio in the diagnosis of infectious mononucleosis by analysis of a large cohort of monospot test results","volume":"35","author":"Lennon","year":"2010","journal-title":"Clin. Otolaryngol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1186\/1743-422X-7-252","article-title":"Measurement of epstein-barr virus DNA load using a novel quantification standard containing two EBV DNA targets and SYBR Green I dye","volume":"7","author":"Lay","year":"2010","journal-title":"Virol. J."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.1749-4486.2011.02367.x","article-title":"Use of the absolute lymphocyte count in the diagnosis of infectious mononucleosis","volume":"36","author":"Biggs","year":"2011","journal-title":"Clin. Otolaryngol."}],"container-title":["Medicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2305-6320\/7\/4\/21\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T13:45:11Z","timestamp":1760363111000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2305-6320\/7\/4\/21"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,22]]},"references-count":52,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2020,4]]}},"alternative-id":["medicines7040021"],"URL":"https:\/\/doi.org\/10.3390\/medicines7040021","relation":{},"ISSN":["2305-6320"],"issn-type":[{"value":"2305-6320","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,22]]}}}